FDA Adverse Event Malfunction Summary report: N

2.7MM CORTEX SCREW SELF-TAPPING 20MM

MDR report key: 6676862 · Received June 29, 2017

Report

Report Number
1719045-2017-10611
Event Type
Malfunction
Date Received
June 29, 2017
Date of Event
June 1, 2017
Report Date
June 1, 2017
Manufacturer
SYNTHES MONUMENT
Product Code
HWC
PMA / PMN Number
K112583
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
LA, US
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

ADDITIONAL PATIENT ID (B)(6). ADDITIONAL DEVICE PRODUCT CODE: KTW. UDI# (B)(4). EVENT OCCURRED INTRAOPERATIVE. DEVICE WAS NOT IMPLANTED/EXPLANTED. DEVICE IS NOT EXPECTED TO BE RETURNED FOR MANUFACTURER REVIEW/INVESTIGATION. DEVICE EVALUATION/INVESTIGATION COULD NOT BE COMPLETED; NO CONCLUSION COULD BE DRAWN AS PRODUCT WAS NOT RETURNED TO MANUFACTURER. DEVICE HISTORY RECORDS REVIEW COULD NOT BE COMPLETED WITHOUT LOT NUMBER. DEVICE WAS USED FOR TREATMENT, NOT DIAGNOSIS. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2017, PATIENT UNDERWENT SURGERY FOR A LEFT OPEN DISTAL RADIUS FRACTURE. DURING THE SURGERY, A 2.7 CORTEX SCREW FROM A SMALL FRAGMENT SET BROKE. THE SCREW SHAFT WAS LEFT IN THE BONE AND THE SCREW HEAD WAS REMOVED. IT WAS THE LAST SCREW PLACED WHEN IT BROKE. NO ADDITIONAL SCREWS WERE USED. THE SURGERY WAS COMPLETED SUCCESSFULLY WITHOUT FURTHER ISSUES. THERE WAS DELAY IN SURGERY TIME. THE PATIENT OUTCOME WAS REPORTED AS BEING FINE. CONCOMITANT DEVICES REPORTED: 2.4MM VA-LCP 2-CLMN VLR DSTL RADIUS PL 7H HD/5H SHAFT/LEFT (PART # 02.111.751, LOT # UNKNOWN, QUANTITY 1), SCREW DRIVER (PART # UNKNOWN, LOT # UNKNOWN, QUANTITY 1). THIS REPORT IS FOR ONE (1) 2.7MM CORTEX SCREW. THIS IS REPORT 1 OF 1 FOR (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
458398 2.7MM CORTEX SCREW SELF-TAPPING 20MM SCREW,FIXATION,BONE HWC SYNTHES MONUMENT

Patients

Seq Age Sex Outcome Treatment
1 66 YR